Validation of the rheumatic disease comorbidity index

Arthritis Care and Research

Volumn 67, Issue 6, 2015, Pages 865-872

  England, Bryant R ^a   Sayles, Harlan ^a   Mikuls, Ted R ^a   Johnson, Dannette S ^b   Michaud, Kaleb ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RHEUMATOID FACTOR;

ADULT; ARTICLE; BODY MASS; CHARLSON COMORBIDITY INDEX; CHARLSON DEYO INDEX; COHORT ANALYSIS; COMORBIDITY; COMORBIDITY ASSESSMENT; COMORBIDITY COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; ELIXHAUSER COMORBIDITY INDEX; ELIXHAUSER POINT SYSTEM; ELIXHAUSER TOTAL SCORE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FUNCTIONAL COMORBIDITY INDEX; HUMAN; ICD-9-CM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PHYSICAL DISABILITY; PREDICTIVE VALUE; RHEUMATIC DISEASE COMORBIDITY INDEX; RHEUMATOID ARTHRITIS; SELF REPORT; UNITED STATES; VALIDATION STUDY; AGED; COST OF ILLNESS; DECISION SUPPORT SYSTEM; DISABILITY; PATHOPHYSIOLOGY; PROGNOSIS; PSYCHOLOGY; REGISTER; REPRODUCIBILITY; RETROSPECTIVE STUDY; RHEUMATIC DISEASES; RISK ASSESSMENT; RISK FACTOR; TIME;

AGED; COMORBIDITY; COST OF ILLNESS; DECISION SUPPORT TECHNIQUES; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGISTRIES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84929937940     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22456     Document Type: Article

References (38)

1. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al., The mortality of rheumatoid arthritis. Arthritis Rheum 1994; 37: 481-94.
2. Myasoedova E, Davis JM III, Crowson CS, Gabriel SE., Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality. Curr Rheumatol Rep 2010; 12: 379-85.
3. Sokka T, Krishnan E, Hakkinen A, Hannonen P., Functional disability in rheumatoid arthritis patients compared with a community population in Finland. Arthritis Rheum 2003; 48: 59-63.
4. Escalante A, del Rincon I., How much disability in rheumatoid arthritis is explained by rheumatoid arthritis? Arthritis Rheum 1999; 42: 1712-21.
5. Radner H, Smolen JS, Aletaha D., Impact of comorbidity on physical function in patients with rheumatoid arthritis. Ann Rheum Dis 2010; 69: 536-41.
6. Charlson ME, Pompei P, Ales KL, MacKenzie CR., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
7. Groll DL, To T, Bombardier C, Wright JG., The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol 2005; 58: 595-602.
8. Kaplan MH, Feinstein AR., The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis 1974; 27: 387-404.
9. Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, et al., Rating chronic medical illness burden in geropsychiatric practice and research: application of the cumulative illness rating scale. Psychiatry Res 1992; 41: 237-48.
10. Von Korff M, Wagner EH, Saunders K., A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992; 45: 197-203.
11. Elixhauser A, Steiner C, Harris DR, Coffey RM., Comorbidity measures for use with administrative data. Med Care 1998; 36: 8-27.
12. Fortin M, Hudon C, Dubois MF, Almirall J, Lapointe L, Soubhi H., Comparative assessment of three different indices of multimorbidity for studies on health-related quality of life. Health Qual Life Outcomes 2005; 3: 74.
13. Rupp I, Boshuizen HC, Jacobi CE, Dinant HJ, van den Bos G., Comorbidity in patients with rheumatoid arthritis: effect on health-related quality of life. J Rheumatol 2004; 31: 58-65.
14. Jonsen A, Clarke AE, Joseph L, Belisle P, Bernatsky S, Nived O, et al., Association of the Charlson Comorbidity Index with mortality in systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2011; 63: 1233-7.
15. Radner H, Smolen JS, Aletaha D., Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis. Rheumatology (Oxford) 2011; 50: 381-8.
16. Espino-Lorenzo P, Manrique-Arija S, Urena I, Jimenez-Nunez FG, Lopez-Lasanta M, Romero-Barco CM, et al., Baseline comorbidities in patients with rheumatoid arthritis who have been prescribed biological therapy: a case control study. Reumatol Clin 2012; 9: 18-23.
17. Rupp I, Boshuizen HC, Roorda LD, Dinant HJ, Jacobi CE, van den Bos G., Poor and good health outcomes in rheumatoid arthritis: the role of comorbidity. J Rheumatol 2006; 33: 1488-95.
18. Krishnan E, Hakkinen A, Sokka T, Hannonen P., Impact of age and comorbidities on the criteria for remission and response in rheumatoid arthritis. Ann Rheum Dis 2005; 64: 1350-2.
19. Linde L, Sorensen J, Ostergaard M, Horslev-Petersen K, Rasmussen C, Jensen DV, et al., What factors influence the health status of patients with rheumatoid arthritis measured by the SF-12v2 health survey and the health assessment questionnaire? J Rheumatol 2009; 36: 2183-9.
20. Southern DA, Quan H, Ghali WA., Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data. Med Care 2004; 42: 355-60.
21. Lieffers JR, Baracos VE, Winget M, Fassbender K., A comparison of Charlson and Elixhauser comorbidity measures to predict colorectal cancer survival using administrative health data. Cancer 2011; 117: 1957-65.
22. Michaud K, Wolfe F., Comorbidities in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007; 21: 885-906.
23. Wolfe F, Michaud K, Li T, Katz RS., Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia. J Rheumatol 2010; 37: 305-15.
24. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
25. Kerr G, Aujero M, Richards J, Sayles H, Davis L, Cannon G, et al., Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications. Arthritis Care Res (Hoboken) 2014; 66: 1619-26.
26. Deyo RA, Cherkin DC, Ciol MA., Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-9.
27. Van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ., A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care 2009; 47: 626-33.
28. Mikuls TR, Fay BT, Michaud K, Sayles H, Thiele GM, Caplan L, et al., Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry. Rheumatology (Oxford) 2011; 50: 101-9.
29. Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP., Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983; 26: 1346-53.
30. Wolfe F, Michaud K, Pincus T., Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire. Arthritis Rheum 2004; 50: 3296-305.
31. Burnham KP, Anderson DR., Multimodel inference: understanding AIC and BIC in model selection. Sociol Methods Res 2004; 33: 261-304.
32. Yazici Y, Bergman M, Pincus T., Time to score quantitative rheumatoid arthritis measures: 28-joint count, disease activity score, health assessment questionnaire (HAQ), multidimensional HAQ (MDHAQ), and routine assessment of patient index data (RAPID) scores. J Rheumatol 2008; 35: 603-9.
33. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL., Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
34. Gabriel SE, Crowson CS, O'Fallon WM., A comparison of two comorbidity instruments in arthritis. J Clin Epidemiol 1999; 52: 1137-42.
35. Drossaers-Bakker KW, de Buck M, van Zeben D, Zwinderman AH, Breedveld FC, Hazes JM., Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum 1999; 42: 1854-60.
36. Chang TI, Paik J, Greene T, Miskulin DC, Chertow GM., Updated comorbidity assessments and outcomes in prevalent hemodialysis patients. Hemodial Int 2010; 14: 478-85.
37. Shahouri SH, Michaud K, Mikuls TR, Caplan L, Shaver TS, Anderson JD, et al., Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteria. Arthritis Rheum 2011; 63: 3204-15.
38. Dominick KL, Dudley TK, Coffman CJ, Bosworth HB., Comparison of three comorbidity measures for predicting health service use in patients with osteoarthritis. Arthritis Rheum 2005; 53: 666-72.